INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GRAIL, Inc. of Class Action Lawsuit and Upcoming Deadlines – GRALNEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against GRAIL, Inc. (“Grail” or the “Company”) (
NASDAQ: GRAL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
GRAL Investors Have Opportunity to Lead GRAIL, Inc. Securities Fraud Lawsuit with the Schall Law FirmThe Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GRAIL, Inc. (“Grail” or “the Company”) (
NASDAQ: GRAL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Rosen Law Firm Urges GRAIL, Inc. (NASDAQ: GRAL) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of GRAIL, Inc. (
NASDAQ: GRAL) between May 13, 2025 and February 19, 2026, inclusive (the “Class Period”). GRAIL, Inc. is a commercial stage healthcare company.
SHAREHOLDER CLASS ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Grail (GRAL) Investors of Securities Class Action Deadline on August 4, 2026Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Grail, Inc. (“Grail” or the “Company”) (
NASDAQ: GRAL) and reminds investors of the August 4, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Investor Notice: Robbins LLP Informs Investors of the Grail, Inc. Class Action LawsuitRobbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Grail, Inc. (
NASDAQ: GRAL) securities between May 13, 2025, and February 19, 2026. Grail, Inc. describes itself as a commercial stage healthcare company with a focus on early cancer detection through screening methodology.
GRAL Investors Have Opportunity to Join GRAIL, Inc. Fraud Investigation with the Schall Law FirmThe Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of GRAIL, Inc. (“GRAIL” or “the Company”) (
NASDAQ: GRAL) for violations of the securities laws.
Kaplan Fox Alerts Investors of Grail, Inc. (GRAL) to an Investigation of Potential Securities Law ViolationsSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Kaplan Fox Alerts Investors of Grail, Inc. (GRAL) to an Investigation of Potential Securities Law ViolationsNEW YORK, NY - February 27, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Grail, Inc. (“Grail” or the “Company”) (Nasdaq: GRAL).
Grail, Inc. (NASDAQ: GRAL) Shareholder Investigation - Kaplan Fox Reviewing Potential ClaimsSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Grail, Inc. (NASDAQ: GRAL) Shareholder Investigation - Kaplan Fox Reviewing Potential ClaimsNEW YORK, NY - February 26, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Grail, Inc. (“Grail” or the “Company”) (Nasdaq: GRAL).
Grail, Inc. (GRAL) Securities Investigation Announced by Kaplan Fox & Kilsheimer LLPNEW YORK, NY - February 25, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Grail, Inc. (“Grail” or the “Company”) (Nasdaq: GRAL).
Grail, Inc. (GRAL) Securities Investigation Announced by Kaplan Fox & Kilsheimer LLPSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Grail Investor ALERT: Kaplan Fox is Investigating Grail, Inc. (NASDAQ: GRAL) for Potential Securities Law ViolationsSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Grail Investor ALERT: Kaplan Fox is Investigating Grail, Inc. (NASDAQ: GRAL) for Potential Securities Law ViolationsNEW YORK, NY - February 24, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Grail, Inc. (“Grail” or the “Company”) (Nasdaq: GRAL).
GRAL ALERT: Kaplan Fox is Investigating Grail, Inc. (NASDAQ: GRAL) for Potential Securities Law ViolationsNEW YORK, NY - February 23, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Grail, Inc. (“Grail” or the “Company”) (Nasdaq: GRAL).
GRAL ALERT: Kaplan Fox is Investigating Grail, Inc. (NASDAQ: GRAL) for Potential Securities Law ViolationsSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Grail Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Grail, Inc. (
NASDAQ: GRAL). The investigation focuses on Grail’s executive officers and whether investor losses may be recovered under federal securities laws.
Strategic Buy Lights Up This Biotech Stock: Time to Invest?Life sciences company Illumina Inc. (
NASDAQ: ILMN) stock surged over 10% following its announcement of the acquisition of Fluent Biosciences.
